TRMK Stock Analysis: Trustmark | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 2.586m USD | 12M Return: 21.2% | US8984021027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.3M
EPS Trend: 94.3%
Qual. Beats: 0
Rev. Trend: 73.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Trustmark Corporation (TRMK) is a U.S. bank holding company headquartered in Jackson, Mississippi, that operates primarily through its subsidiary, Trustmark National Bank. Founded in 1889, the company runs two reportable segments: General Banking and Wealth Management, serving both individual consumers and corporate clients. As a mid-cap regional bank, Trustmark falls under the GICS Regional Banks sub-industry and operates under the bank holding company structure, which subjects it to supervision by the Federal Reserve and deposit insurance by the FDIC.
Through General Banking, Trustmark offers deposit products such as checking, savings, money market, and certificate of deposit accounts (including IRAs), as well as treasury management services. Its lending activities span commercial and industrial loans, income-producing and owner-occupied commercial real estate, construction and land development financing, plus installment and home equity loans and lines of credit. The company also provides mortgage banking services, including construction financing, origination of conventional and government-insured loans, secondary marketing, and mortgage servicing.
The Wealth Management segment delivers trust and estate administration, investment management for individuals, employee benefit plans, and charitable foundations, along with institutional custody, financial and estate planning, and retirement plan services. Trustmark additionally participates in community development lending as an intermediary for loans and investments in low-income communities, a function typically associated with Community Reinvestment Act (CRA) compliance obligations of U.S. banks.
- Net interest margin expands as deposit costs ease and asset yields rise
- Commercial real estate loan portfolio faces heightened credit quality scrutiny
- Wealth Management fee income grows on rising AUM and new client acquisition
| Net Income: 235.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.22 > 1.0 |
| NWC/Revenue: -1.16k% < 20% (prev -1.22k%; Δ 59.04% < -1%) |
| CFO/TA 0.01 > 3% & CFO 280.8m > Net Income 235.6m |
| Net Debt (-2.96b) to EBITDA (290.3m): -10.19 < 3 |
| Current Ratio: 0.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.2m) vs 12m ago -4.15% < -2% |
| Gross Margin: 72.24% > 18% (prev 62.59%; Δ 9.65% > 0.5%) |
| Asset Turnover: 5.69% > 50% (prev 6.01%; Δ -0.32% > 0%) |
| Interest Coverage Ratio: 0.85 > 6 (EBIT TTM 250.3m / Interest Expense TTM 293.0m) |
| A: -0.65 (Total Current Assets 3.92b - Total Current Liabilities 16.4b) / Total Assets 19.1b |
| B: 0.11 (Retained Earnings 2.17b / Total Assets 19.1b) |
| C: 0.01 (EBIT TTM 250.3m / Avg Total Assets 19.0b) |
| D: 0.12 (Book Value of Equity 2.09b / Total Liabilities 17.0b) |
| Altman-Z'' = -3.69 = D |
As of November 11, 2026, the stock is trading at USD 45.40 with a total of 300,584 shares traded. Over the past week, the price has changed by +0.87%, over one month by +2.02%, over three months by -3.49% and over the past year by +21.23%.
Current recommended Stop Loss: 44.00 (which is 3.1% or 1.2 ATR below the current price).
Trustmark has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold TRMK.
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 49.8 | 9.7% |
P/E Trailing = 11.1825
P/E Forward = 11.8906
P/S = 3.1528
P/B = 1.2601
P/EG = 2.2868
Revenue TTM = 1.08b USD
EBIT TTM = 250.3m USD
EBITDA TTM = 290.3m USD
Long Term Debt = 458.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = 341.3m USD (from shortTermDebt, last quarter)
Debt = 721.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 37.1m
Net Debt = -2.96b USD (calculated: Debt 721.6m - CCE 3.68b)
Enterprise Value = 2.59b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.85 (Ebit TTM 250.3m / Interest Expense TTM 293.0m)
EV/FCF = 10.58x (Enterprise Value 2.59b / FCF TTM 244.3m)
FCF Yield = 9.45% (FCF TTM 244.3m / Enterprise Value 2.59b)
FCF Margin = 22.66% (FCF TTM 244.3m / Revenue TTM 1.08b)
Net Margin = 21.85% (Net Income TTM 235.6m / Revenue TTM 1.08b)
Gross Margin = 72.24% ((Revenue TTM 1.08b - Cost of Revenue TTM 299.2m) / Revenue TTM)
Gross Margin QoQ = 73.06% (prev 69.76%)
Tobins Q-Ratio = 0.14 (Enterprise Value 2.59b / Total Assets 19.1b)
Interest Expense / Debt = 40.61% (Interest Expense 293.0m / Debt 721.6m)
Taxrate = 19.56% (57.3m / 292.9m)
NOPAT = 201.3m (EBIT 250.3m * (1 - 19.56%))
Current Ratio = 0.24 (Total Current Assets 3.92b / Total Current Liabilities 16.4b)
Debt / Equity = 0.34 (Debt 721.6m / totalStockholderEquity, last quarter 2.09b)
Debt / EBITDA = -10.19 (Net Debt -2.96b / EBITDA 290.3m)
Debt / FCF = -12.10 (Net Debt -2.96b / FCF TTM 244.3m)
Total Stockholder Equity = 2.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.24% (Net Income 235.6m / Total Assets 19.1b)
RoE = 11.10% (Net Income TTM 235.6m / Total Stockholder Equity 2.12b)
RoCE = 9.70% (EBIT 250.3m / Capital Employed (Equity 2.12b + L.T.Debt 458.8m))
RoIC = 6.72% (NOPAT 201.3m / Invested Capital 3.00b)
WACC = 13.08% (E(2.59b)/V(3.31b) * Re(7.61%) + D(721.6m)/V(3.31b) * Rd(40.61%) * (1-Tc(0.20)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -93.97 | Cagr: -2.19%
[DCF] Terminal Value 58.08% ; FCFF base≈259.1m ; Y1≈231.3m ; Y5≈193.6m
[DCF] Fair Price = 81.38 (EV 1.75b - Net Debt -2.96b = Equity 4.70b / Shares 57.8m; r=13.08% [WACC]; 5y FCF grow -13.18% → 2.50% )
EPS Correlation: 94.32 | EPS CAGR: 17.40% | SUE: 0.0 | # QB: 0
Revenue Correlation: 73.56 | Revenue CAGR: 13.13% | SUE: 0.68 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.01 | Chg30d=+0.50% | Revisions=+67% | Analysts=6
EPS current Year (2026-12-31): EPS=3.98 | Chg30d=-0.08% | Revisions=-29% | GrowthEPS=+7.6% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=4.29 | Chg30d=+0.19% | Revisions=+67% | GrowthEPS=+7.9% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +53% (up=13, down=3)